Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Long-term Finasteride treatment reduces depression better than short-term treatment in rats.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Dihydrotestosterone (DHT) worsens heart enlargement, and blocking it may help prevent heart issues.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Immune cells help keep skin healthy and repair it, but imbalance can cause disease.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

New understanding and treatments for hair loss are improving, but more research is needed.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Hura crepitans and its compound daphne factor F3 may help treat hair loss by blocking a specific hair growth inhibitor.

Fermentation of Finasteride with Ocimum sanctum L. creates new metabolite that inhibits tyrosinase.

mTOR inhibitors may help treat lung fibrosis.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.